Publications by authors named "Jia-Fei Chen"
Article Synopsis
- A study was conducted to assess the effectiveness and safety of combining transcatheter arterial chemoembolization (TACE) with lenvatinib and camrelizumab for treating unresectable hepatocellular carcinoma (uHCC).
- The research involved 55 patients across nine hospitals in China and measured outcomes like tumor response rate and surgical conversion rate.
- Results showed a significant overall response rate of 76.4%, with 16.4% achieving complete response, and a notable 43.6% of patients experienced severe treatment-related side effects.
Double intussusceptions with small intestinal adenoma in pregnancy.
Eur J Obstet Gynecol Reprod Biol
November 2013